Skip to content 
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida. more
| Time Frame | CNMD | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 2.48% | 0.91% | 2.13% |
| 1-Month Return | -4.12% | -0.72% | -0.47% |
| 3-Month Return | -4.34% | 2.24% | 1.29% |
| 6-Month Return | -22.85% | 19.1% | 7.71% |
| 1-Year Return | -33.33% | 7.15% | 14.7% |
| 3-Year Return | -57.81% | 16.96% | 67.75% |
| 5-Year Return | -66.08% | 33.23% | 76.25% |
| 10-Year Return | 13.7% | 142.74% | 271.83% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 1.01B | 1.05B | 1.24B | 1.31B | 1.37B | [{"date":"2021-12-31","value":73.52,"profit":true},{"date":"2022-12-31","value":76.05,"profit":true},{"date":"2023-12-31","value":90.55,"profit":true},{"date":"2024-12-31","value":95.07,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 442.60M | 474.23M | 568.50M | 573.98M | 634.12M | [{"date":"2021-12-31","value":69.8,"profit":true},{"date":"2022-12-31","value":74.79,"profit":true},{"date":"2023-12-31","value":89.65,"profit":true},{"date":"2024-12-31","value":90.52,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 568.04M | 571.25M | 676.25M | 733.03M | 740.61M | [{"date":"2021-12-31","value":76.7,"profit":true},{"date":"2022-12-31","value":77.13,"profit":true},{"date":"2023-12-31","value":91.31,"profit":true},{"date":"2024-12-31","value":98.98,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 56.21% | 54.64% | 54.33% | 56.08% | 53.87% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.21,"profit":true},{"date":"2023-12-31","value":96.66,"profit":true},{"date":"2024-12-31","value":99.78,"profit":true},{"date":"2025-12-31","value":95.85,"profit":true}] |
| Operating Expenses | 458.32M | 501.19M | 555.64M | 532.71M | 610.48M | [{"date":"2021-12-31","value":75.07,"profit":true},{"date":"2022-12-31","value":82.1,"profit":true},{"date":"2023-12-31","value":91.02,"profit":true},{"date":"2024-12-31","value":87.26,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 109.72M | 70.05M | 120.60M | 200.33M | 130.13M | [{"date":"2021-12-31","value":54.77,"profit":true},{"date":"2022-12-31","value":34.97,"profit":true},{"date":"2023-12-31","value":60.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":64.96,"profit":true}] |
| Total Non-Operating Income/Expense | (72.10M) | (169.82M) | (79.49M) | (74.59M) | - | [{"date":"2021-12-31","value":-7209700000,"profit":false},{"date":"2022-12-31","value":-16982100000,"profit":false},{"date":"2023-12-31","value":-7948900000,"profit":false},{"date":"2024-12-31","value":-7459400000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 73.11M | (70.86M) | 80.83M | 163.03M | 71.12M | [{"date":"2021-12-31","value":44.84,"profit":true},{"date":"2022-12-31","value":-43.47,"profit":false},{"date":"2023-12-31","value":49.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":43.62,"profit":true}] |
| Income Taxes | 10.56M | 9.72M | 16.37M | 30.61M | 24.06M | [{"date":"2021-12-31","value":34.51,"profit":true},{"date":"2022-12-31","value":31.76,"profit":true},{"date":"2023-12-31","value":53.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":78.62,"profit":true}] |
| Income After Taxes | 62.54M | (80.58M) | 64.46M | 132.42M | - | [{"date":"2021-12-31","value":47.23,"profit":true},{"date":"2022-12-31","value":-60.85,"profit":false},{"date":"2023-12-31","value":48.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 62.54M | (80.58M) | 57.97M | 132.42M | - | [{"date":"2021-12-31","value":47.23,"profit":true},{"date":"2022-12-31","value":-60.85,"profit":false},{"date":"2023-12-31","value":43.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 62.54M | (80.58M) | 64.46M | 132.42M | 47.05M | [{"date":"2021-12-31","value":47.23,"profit":true},{"date":"2022-12-31","value":-60.85,"profit":false},{"date":"2023-12-31","value":48.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":35.53,"profit":true}] |
| EPS (Diluted) | 3.21 | 2.65 | 3.45 | 4.16 | 4.15 | [{"date":"2021-12-31","value":77.16,"profit":true},{"date":"2022-12-31","value":63.7,"profit":true},{"date":"2023-12-31","value":82.93,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":99.76,"profit":true}] |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| CNMD | |
|---|---|
| ROA (LTM) | 4.15% |
| ROE (LTM) | 4.78% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| CNMD | |
|---|---|
| Trailing PE | 28.41 |
| Forward PE | 27.03 |
| P/S (TTM) | 0.95 |
| P/B | 1.31 |
| Price/FCF | 27 |
| EV/R | 1.56 |
| EV/Ebitda | 20.94 |
| PEG | 5.29 |
CONMED Corporation (CNMD) share price today is $41.67
Yes, Indians can buy shares of CONMED Corporation (CNMD) on Vested. To buy
Yes, you can purchase fractional shares of CONMED Corporation (CNMD) via the Vested app. You can start investing in CONMED Corporation (CNMD) with a minimum investment of $1.
You can invest in shares of CONMED Corporation (CNMD) via Vested in three simple steps:
The 52-week high price of CONMED Corporation (CNMD) is $64.79. The 52-week low price of CONMED Corporation (CNMD) is $35.37.
The price-to-earnings (P/E) ratio of CONMED Corporation (CNMD) is 28.4094
The price-to-book (P/B) ratio of CONMED Corporation (CNMD) is 1.31
The dividend yield of CONMED Corporation (CNMD) is 1.44%
The market capitalization of CONMED Corporation (CNMD) is $1.31B
The stock symbol (or ticker) of CONMED Corporation is CNMD
Consider the share price of CONMED Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether CONMED Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in CONMED Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the CONMED Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of CONMED Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that CONMED Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
